EUVIMEDEUVIMED entdecken
Crossref

Implementation of the recommended immunohistochemistry algorithm for classification of peripheral T ‐cell lymphoma, not otherwise specified into the prognostically significant GATA3 and TBX21 subtypes

Surabhi Jain iD, Aijaz Ahmad, Ambreen Jan, Ajay Gogia, Mukul Aggarwal, Ganesh Kumar Viswanathan, Trisha Mandal, Atul Sharma, Ranjit Sahoo, Mehar Chand Sharma, Sameer Bakhshi iD, Lalit Kumar und 1 weitere

International Journal of Laboratory Hematology · 2024

DOI: 10.1111/ijlh.14325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2024. Verfasst von Surabhi Jain und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: GATA3 Transcription Factor, T-Box Domain Proteins, Lymphoma, T-Cell, Peripheral, Algorithms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: AIIMS-A653, All India Institute of medical sciences, New Delhi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Current molecular research has shown the several oncogenic pathways that give rise to the peripheral T‐cell lymphoma, not otherwise defined (PTCL, NOS) subtypes, which alter prognosis and might have predictive value. This study was conducted to assess the immunohistochemistry (IHC) algorithm by Amador et al for the subtyping of PTCL, NOS and determine its applicability in relation to the clinicopathological profile.

Methods

This study included 43 patients with PTCL, NOS diagnosis. Following the use of IHC for the transcription factors GATA3, TBX21, CCR4, and CXCR3, two pathologists subtyped the samples. Comprehensive clinicopathological correlation was carried out.

Results

Applying the algorithm of Amador et al., cases were classified into GATA3 (20), TBX21 (15), and unclassified (8) subtypes. No significant association with clinical parameters of subtypes or CD4/ CD8 positivity was observed. Although a higher proportion of cases in the TBX21 subgroup showed a polymorphic population compared with the GATA3 subgroup, which had a monomorphic population, no significant p ‐value (0.111) was observed. Two Lennert lymphomas were classified into the GATA3 subgroup. Multivariate analysis showed no significant difference in overall survival ( p ‐value = 0.105) and progression‐free survival ( p ‐value = 0.0509) between IHC‐defined subtypes; trends indicate that overall survival and progression‐free survival are worse in the GATA3 subgroup.

Conclusion

Although the algorithm is reproducible, a proportion of cases remains unclassifiable and may require additional investigation and gene expression profiling. The GATA3 subgroup was found to have a monomorphic population with a poor overall prognosis and thus requires a larger sample size for validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GATA3 Transcription FactorT-Box Domain ProteinsLymphoma, T-Cell, PeripheralAlgorithmsImmunohistochemistryHumansFemaleMaleMiddle AgedAdultPrognosisAgedAged, 80 and overBiomarkers, TumorT-bet Transcription Factor

Stichwörter der Autor:innen

GATA3PTCLTBX21subclassification

Substanzen

GATA3 Transcription FactorT-Box Domain ProteinsGATA3 protein, humanT-bet Transcription FactorBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.

ORCID-Profile: Surabhi Jain, Sameer Bakhshi, Saumyaranjan Mallick

Förderung

  • AIIMS-A653, All India Institute of medical sciences, New Delhi

Zitieren

APA

Jain, S., Ahmad, A., Jan, A., Gogia, A., Aggarwal, M., Viswanathan, G. K., Mandal, T., Sharma, A., Sahoo, R., Sharma, M. C., Bakhshi, S., Kumar, L., & Mallick, S. (2024). Implementation of the recommended immunohistochemistry algorithm for classification of peripheral T ‐cell lymphoma, not otherwise specified into the prognostically significant GATA3 and TBX21 subtypes. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14325

Vancouver

Jain S, Ahmad A, Jan A, Gogia A, Aggarwal M, Viswanathan GK, et al. Implementation of the recommended immunohistochemistry algorithm for classification of peripheral T ‐cell lymphoma, not otherwise specified into the prognostically significant GATA3 and TBX21 subtypes. International Journal of Laboratory Hematology. 2024. doi:10.1111/ijlh.14325

BibTeX
@article{Jain2024,
  author = {Jain, Surabhi and Ahmad, Aijaz and Jan, Ambreen and Gogia, Ajay and Aggarwal, Mukul and Viswanathan, Ganesh Kumar and Mandal, Trisha and Sharma, Atul and Sahoo, Ranjit and Sharma, Mehar Chand and Bakhshi, Sameer and Kumar, Lalit and Mallick, Saumyaranjan},
  title = {Implementation of the recommended immunohistochemistry algorithm for classification of peripheral T ‐cell lymphoma, not otherwise specified into the prognostically significant GATA3 and TBX21 subtypes},
  journal = {International Journal of Laboratory Hematology},
  year = {2024},
  doi = {10.1111/ijlh.14325}
}
Kostenlos starten →